Grail: Galleri Test Delivers the Holy Grail for Cancer Early Detection – Blood Test Identifies Over 50 Types of Cancer!

Reading Time: 2 minutes
Grail (GRAL) aims to deliver the holy grail for early-stage cancer detection with the Galleri test. A simple blood test can identify over 50 types of cancer as a so-called multi-cancer early detection (MCED) solution and is a valuable addition, as 70% of all cancer deaths occur from cancer types for which there are no recommended screenings. 86% of cancer cases are not detected during recommended screenings. The chance of survival can increase by fourfold with early diagnoses. Detailed results of the PATHFINDER 2 study are set to be presented...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.